| Literature DB >> 18276643 |
Dmitry A Rodionov1, Jessica De Ingeniis, Chiara Mancini, Flavio Cimadamore, Hong Zhang, Andrei L Osterman, Nadia Raffaelli.
Abstract
A novel family of transcription factors responsible for regulation of various aspects of NAD synthesis in a broad range of bacteria was identified by comparative genomics approach. Regulators of this family (here termed NrtR for Nudix-related transcriptional regulators), currently annotated as ADP-ribose pyrophosphatases from the Nudix family, are composed of an N-terminal Nudix-like effector domain and a C-terminal DNA-binding HTH-like domain. NrtR regulons were reconstructed in diverse bacterial genomes by identification and comparative analysis of NrtR-binding sites upstream of genes involved in NAD biosynthetic pathways. The candidate NrtR-binding DNA motifs showed significant variability between microbial lineages, although the common consensus sequence could be traced for most of them. Bioinformatics predictions were experimentally validated by gel mobility shift assays for two NrtR family representatives. ADP-ribose, the product of glycohydrolytic cleavage of NAD, was found to suppress the in vitro binding of NrtR proteins to their DNA target sites. In addition to a major role in the direct regulation of NAD homeostasis, some members of NrtR family appear to have been recruited for the regulation of other metabolic pathways, including sugar pentoses utilization and biogenesis of phosphoribosyl pyrophosphate. This work and the accompanying study of NiaR regulon demonstrate significant variability of regulatory strategies for control of NAD metabolic pathway in bacteria.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18276643 PMCID: PMC2330246 DOI: 10.1093/nar/gkn047
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.Overview of NAD biosynthesis and salvage pathways and a link with other metabolic pathways via ADP-ribose. NrtR-controlled steps are indicated by a red asterisk. Metabolic enzymes and uptake transporters are shown by solid and dashed lines, respectively and colored by a metabolic pathway. De novo NAD biosynthesis pathway utilizes L-aspartate oxydase (the product of nadB gene), quinolinate synthase (nadA) and quinolinate phosphoribosyltransferase (nadC). Universal NaMN to NAD pathway utilizes nicotinate mononucleotide adenylyltransferase (nadD), and NAD synthetase (nadE). In Nam salvage pathways, NaMN is synthesized from NA and Nam precursors that are taken up by niacin transporter (niaP). Salvage I pathway involves nicotinamide deaminase (pncA), and nicotinate phosphoribosyltransferase (pncB). Salvage II pathway uses nicotinamide phosphoribosyltransferase (nadV), and nicotinamide mononucleotide adenylyltransferase (nadM) (31,41). In the third salvage pathway, NAD is synthesized from the exogenous RNam precursor delivered by the RNam transporter (pnuC) via consecutive reactions catalyzed by two separate domains of NadR, nicotinamide mononucleotide adenylyltransferase (nadR), and nicotinamide riboside kinase (nadR)(47,48). Endogenous Nam and ADP-ribose are generated by enzymes hydrolyzing the N-glycosidic bond of NAD. Enzymes linked to NAD metabolism via ADP-ribose are ribose phosphate pyrophosphokinase (prs); ribose phosphate isomerase (rpi), ribulose phosphate epimerase (rpe), transketolase (tkt), transaldolase (tal), as well as xylose (xylAB), and arabinose (araBAD) utilization enzymes. Asp, aspartate; Trp, tryptophan; IA, iminoaspartate; Qa, quinolinic acid; NaMN, nicotinate mononucleotide; NaAD, nicotinate adenine dinucleotide; NA, nicotinic acid; Nam, nicotinamide; RNam, ribosyl nicotinamide; NMN, nicotinamide mononucleotide; ADPR, ADP-ribose; PRPP, phosphoribosyl pyrophosphate; Rib-P, ribose-5-phosphate; Xyl-P, xylulose-5-phosphate; Ara, l-arabinose; Xyl, d-xylose.
Figure 2.Genomic organization of nrtR-containing loci involved in NAD metabolism (A), pentose utilization (B) and other pathways (C). Genes encoding the predicted NrtR regulator are shown by red arrows; the color code and the abbreviations for other genes correspond to those used in Figure 1. Red circles indicate the predicted NrtR-binding sites.
Figure 3.Maximum likelihood phylogenetic tree and DNA recognition motifs for the NrtR family of transcriptional regulators. NrtR proteins recognizing the same DNA motif are grouped (the group names are given), and the corresponding motif sequence logos are shown on the left and right sides. Species content of the NrtR groups, as well as the content of corresponding regulons and the NrtR-regulated pathways are summarized in Table 1. Genome context of nrtR genes is shown by squares with colors corresponding to the color code of functional roles in Figure 1. NrtR proteins possessing intact Nudix signature are in red. Proteins from B. thetaiotaomicron and E. faecalis with solved 3D structures are highlighted. Proteins studied in this work are boxed. The numbers indicate the number of bootstrap replications, out of 100, that support each node on the tree.
Operon structure for nrtR genes and predicted NrtR sites in bacteria
| Organism | NrtR operon/regulon structure | NrtR-regulated pathway | NrtR DNA-binding sequence logo profile |
|---|---|---|---|
| NAD( | Cyanobacteria | ||
| NAD( | Cyanobacteria | ||
| NAD( | Cyanobacteria | ||
| NAD( | Actinobacteria-1a | ||
| NAD( | Actinobacteria-1a | ||
| NAD( | Actinobacteria-1a | ||
| NAD( | Actinobacteria-1a | ||
| NAD( | Actinobacteria-1b | ||
| NAD( | Actinobacteria-1b | ||
| NAD( | Actinobacteria-1b | ||
| ADPR | Actinobacteria-2a | ||
| ? | Actinobacteria-2b | ||
| ? | Actinobacteria-2b | ||
| NAD( | Firmicutes-1a | ||
| NAD( | Firmicutes-1a | ||
| NAD( | Firmicutes-1b | ||
| NAD( | Firmicutes-2a | ||
| NAD( | Firmicutes-2b | ||
| NAD( | Gammaproteo-1a | ||
| NAD( | Gammaproteo-1a | ||
| ? | Gammaproteo-1a | ||
| NAD( | Gammaproteo-1a | ||
| NAD( | Gammaproteo-1a | ||
| NAD( | Gammaproteo-1b | ||
| NAD( | Gammaproteo-1b | ||
| NAD( | Gammaproteo-1c | ||
| pncA-nrtR<#>pncB | NAD( | Gammaproteo-1c | |
| NAD( | Cytophaga | ||
| NAD( | Chloroflexi | ||
| NAD( | Pirellula | ||
| Xyl | Bacteroidetes-1a | ||
| Ara | Bacteroidetes-1b | ||
| Ara | Bacteroidetes-1b | ||
| Xyl, Ara, PP | Bacteroidetes-1b | ||
| Ara | Bacteroidetes-1b | ||
| Xyl, PP | Bacteroidetes-1c | ||
| Ara | Bacteroidetes-1c | ||
| Xyl | Bacteroidetes-1c |
aGenes forming one putative operon (with spacer <100 bp) are separated by dashes. Different loci are separated by semicolons. The direction of transcription in divergons (two oppositely directed transcriptional units) is shown by angel brackets. Predicted NrtR-binding sites are denoted by ‘#’. Functions of NrtR-regulated genes are described in the legend to Figure 1. SufS is a homologue of IscS cysteine desulfurase involved in the in vivo maturation of Fe-S clusters, possibly necessary to assemble NadAB complex. Other predicted NrtR-regulated genes of unknown function are denoted nrtX and nrtY.
bBiochemical pathways predicted to be regulated by NrtR are abbreviated according to Figure 1. Functional roles involved in NAD synthesis: d, de novo biosynthesis; u, universal NAD synthesis; s1, s2 and s3 stand for salvage pathways I, II, and III; p, PRPP synthesis; t, niacin transport. Other metabolic pathways are pentose-phosphate pathway (PP), xylose (Xyl), arabinose (Ara) utilization and reversible protein ADP-ribosylation (ADPR).
cGenomes are grouped according to the predicted DNA-binding profiles (see the phylogenetic tree of NrtR proteins on Figure 3), and in most cases, the NrtR groups coincide with the taxonomic groups of organisms.
Figure 4.Crystal structures and ligand-binding sites of E. faecalis EF2700 (A) and B. thetaiotaomicron BT0354 (B). Structures of EF2700 (PDB accession number 2FML) and BT0354 (2FB1) were solved at the Midwest Center for Structural Genomics. The C-terminal wHTH domains are shown in grey, and the N-terminal Nudix domains of each monomer are shown in cyan and green, respectively. The co-crystallized glycerol and phosphate molecules are indicated. In the insets are the close-ups of the Nudix domain active sites with a modeled ADPR molecule in EF2700 and a Rib-P molecule in BT0354, respectively, based on the superposition with the Synechocystis sp. NadM–ADPR complex structure. In the binding pocket of BT0354, the Rib-P moiety (R5P) of ADPR is shown as sticks while the rest of the molecule is show as thin lines. Protein residues that are predicted to interact with the bound ligand are also shown as sticks. Dotted lines represent potential hydrogen bonds. Residues Y27B and Y5B of EF2700 and BT0354, respectively, come from the second subunit of the dimer.
Figure 5.EMSA demonstrating specific NrtR binding to DNA. DNA fragments used in the assays are defined by their genomic positions and are shown as dark circles in the top of each panel. (A) EMSA with nadM-nadV DNA fragment (0.7 ng) in the absence (lane 1) and in the presence (lanes 2–5) of increasing syNrtR protein concentrations (0.25, 0.5, 1.0 and 5.0 nM, respectively). The specificity of interaction of syNrtR (2 nM) with DNA fragment (lane 7) was tested by competition with 1 μg polydC/dI (lane 8) and 140 ng unlabeled DNA fragment (lane 9). Lane 6 contains 0.7 ng of the biotylinated DNA fragment only. (B) EMSA with nadE and nadA DNA fragments in the absence (lanes 1 and 5) and in the presence of syNrtR (2 nM) (lanes 2 and 6). The specificity of interaction was tested with polydC/dI (lanes 3 and 7) and unlabeled DNA fragment (lanes 4 and 8). (C) EMSA with prs-nadV DNA fragment in the absence (lane 1) and in the presence of 2 nM soNrtR (lanes 2 and 5) and 5 nM soNrtR (lane 6). Competition assays were performed with 2 nM soNrtR in the presence of polydC/dI (lane 3) and unlabeled DNA (lane 4).
Figure 6.Effect of NAD metabolites on NrtR–DNA binding. (A) Electrophoretic mobility of prs-nadV DNA fragment incubated with purified soNrtR (2 nM) in the absence (lane 1) and in the presence of 100 and 10 μM of the indicated compounds. (B) Electrophoretic mobility of nadM-nadV DNA fragment incubated with increasing concentrations of purified syNrtR in the absence and in the presence of 1 mM NAD, 1 mM ADPR and 1 mM Rib-P.